Return
Company Page
CellType
Founders
CellType is the agentic drug company using AI agents and biological foundation models to simulate human biology and power end-to-end drug discovery. Its core technology, Cell2Sentence, converts single-cell gene expression data into a language that large language models can learn from, enabling virtual human simulations that predict drug responses before clinical trials. Co-developed with Google DeepMind at Yale University and published at ICML, the platform has already discovered and validated a novel cancer treatment signal and is actively working with Top 10 global pharma companies.
Company Founded in 2026
Healthtech & Biotech